Personal and societal health quality lost to tuberculosis

• Published in: PloS one Vol. 4; no. 4; p. e5080
• Main Authors: Miller, Thaddeus L, McNabb, Scott J N, Hilsenrath, Peter, Pasipanodya, Jotam, Weis, Stephen E
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 08.04.2009; Public Library of Science (PLoS)
• Subjects: Adult; Analysis; Care and treatment; Cohort Studies; Complications; Costs; Death; Developed countries; Disability; Disease control; Disease prevention; Estimates; Female; Health policy; Health Status Indicators; Humans; Illnesses; Impairment; Infections; Infectious diseases; Intensive care; Male; Mathematical analysis; Medical research; Middle Aged; Morbidity; Mortality; Mycobacterium; Patients; Personal communication; Prevention; Public health; Public Health and Epidemiology/Health Policy; Public Health and Epidemiology/Health Services Research and Economics; Public Health and Epidemiology/Infectious Diseases; Quality of life; Quality-Adjusted Life Years; Respiratory system agents; Science; Society; Spanish language; Studies; Tuberculosis; Tuberculosis - epidemiology; Tuberculosis - mortality; Tuberculosis - physiopathology; Ventilators; Fort Worth Texas; United States > US; Texas; Tarrant County Texas
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0005080

In developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare. Research has shown that there are chronic pulmonary sequelae in a majority of patients who have completed treatment for pulmonary tuberculosis (PTB). This and other health effects of tuberculosis have not been considered in QALY calculations. Consequently both the burden of tuberculosis on the individual and the value of tuberculosis prevention to society are underestimated. We estimated QALYs lost to pulmonary TB patients from all known sources, and estimated health loss to prevalent TB disease. We calculated values for health during illness and treatment, pulmonary impairment after tuberculosis (PIAT), death rates, years-of-life-lost to death, and normal population health. We then compared the lifetime expected QALYs for a cohort of tuberculosis patients with that expected for comparison populations with latent tuberculosis infection and without tuberculosis infection. Persons with culture-confirmed tuberculosis accrued fewer lifetime QALYs than those without tuberculosis. Acute tuberculosis morbidity cost 0.046 QALYs (4% of total) per individual. Chronic morbidity accounted for an average of 0.96 QALYs (78% of total). Mortality accounted for 0.22 QALYs lost (18% of total). The net benefit to society of averting one case of PTB was about 1.4 QALYs. Tuberculosis, a preventable disease, results in QALYs lost owing to illness, impairment, and death. The majority of QALYs lost from tuberculosis resulted from impairment after microbiologic cure. Successful TB prevention efforts yield more health quality than previously thought and should be given high priority by health policy makers. (Refer to Abstracto S1 for Spanish language abstract).